OXFORD, UK / ACCESS Newswire / June 15, 2026 /Fine Treatment has highlighted increasing interest in non-invasive therapeutic ...
U.S. Market Projected to Hit USD 7.06 Billion by 2035 While Europe Market Expected to Reach USD 6.42 Billion as Aging Male Population Fuels Demand for Advanced BPH Therapies.Austin, United States, May ...
The Society of Interventional Radiology (SIR) has published new practice guidance for the use of prostatic artery embolization (PAE) to treat enlarged prostate (also called benign prostatic ...
JW Pharmaceutical and JW Shinyak Hold Symposium on Benign Prostatic Hyperplasia Treatment "Truepass"
JW Pharmaceutical and JW Shinyak announced on the 10th that they held the "J STAR Symposium" at the Grand Walkerhill Seoul ...
For men with benign prostate hyperplasia, aquablation provides temporary benefits for ejaculation and continence at three months, while holmium laser enucleation of the prostate (HoLEP) has superior ...
Frequent urination, urgency and waking up at night to urinate are often blamed on an enlarged prostate. However, doctors say ...
AngioDynamics (Nasdaq:ANGO) announced today that it received FDA investigational device exemption (IDE) to initiate the ...
Contemporary diagnosis of very low risk prostate cancer in a multi-centered hospital system. Use of the Prostatype P-score to predict adverse pathology (AP) at radical prostatectomy (RP). This is an ...
Prostate health is vital for men over fifty as conditions like BPH, prostatitis, and cancer can affect urinary function and ...
The present study aims to study association of various modifiable risk factors with Prostate Cancer and Benign Prostatic Hyperplasia."BUFFALO, NY — ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results